How Often Is Skin Cancer Misdiagnosed?

Some lesions look fairly harmless at first, or resemble common skin conditions, which can make them harder to identify.

That does not mean a delay in diagnosis is automatically a sign that something has gone wrong. But a mark that is changing, bleeding or not healing should be assessed properly.

If there is uncertainty, it is reasonable to ask for it to be reviewed again.

It Can Happen Occasionally

There is no single, trustworthy percentage that tells us how often skin cancer is misdiagnosed. Studies measure different things, including an initial clinical impression, delayed referral, pathology findings and missed opportunities to reassess a changing lesion. The likelihood also varies by cancer type, location on the body, skin tone and the experience of the clinician examining it.

For most people, the more useful question is not whether a precise figure exists. It’s whether a particular lesion has been properly assessed and whether its behaviour still fits the original diagnosis.

A spot that keeps returning, changes in appearance or fails to respond to treatment deserves another look because persistent change can alter the clinical picture.

When Cancer Is Mistaken for a Benign Skin Condition

Skin cancer may initially be mistaken for eczema, psoriasis, a wart, a cyst, a fungal infection or a harmless mole. This can happen because many early skin cancers are subtle, and common benign conditions are far more frequent. An oncology consultant will consider the lesion itself, its history and any change over time when deciding whether further investigation is needed.

A diagnosis can also evolve as more information becomes available. A lesion may appear low risk during one appointment but become concerning when it grows, bleeds or does not heal as expected. That is why clear safety-netting matters, including advice about what should prompt the patient to return for review.

Why Can Skin Cancer Be Difficult to Recognise?

Many people expect skin cancer to look like a dark, irregular mole. In reality, melanoma can be pink, red, skin-coloured or appear as a streak beneath a nail. Basal cell carcinoma and squamous cell carcinoma can also resemble dry skin, a recurring sore or a patch of inflammation.

The location of a lesion can make diagnosis more difficult as well. The scalp, back, ears, soles of the feet and areas beneath nails are harder to inspect and may not be noticed until a change is more obvious. A thorough assessment should account for both appearance and the practical difficulty of monitoring less visible sites.

Which Types of Skin Cancer Are Most Likely to Be Mistaken for Something Else?

Melanoma, Basal Cell Carcinoma and Squamous Cell Carcinoma

There are several different types of skin cancer, and they can look quite different from one another.

Melanoma may be confused with a benign mole, particularly when it does not follow familiar colour or border patterns. Basal cell carcinoma, often called BCC, may look like a shiny bump, a pale scar-like area or a sore that crusts and returns. Squamous cell carcinoma, or SCC, may resemble a rough scaly patch, a wart or a firm red lump.

Each type needs a different level of urgency and treatment planning. Melanoma and SCC carry a greater risk of spreading than BCC, although any suspected skin cancer needs proper assessment.

Warning Signs That Should Prompt a Reassessment

There are many different skin cancer symptoms you should never ignore. A mole or mark should be reassessed if it changes in size, shape, colour or surface texture. Bleeding, crusting, itching, tenderness and a new raised area can also be relevant, especially when there is no clear explanation. A lesion that looks different from others on the skin, sometimes called an “ugly duckling”, should be assessed with care.

A sore that does not heal within several weeks needs medical review, particularly if it repeatedly scabs over and then breaks down again. The same applies to a rash or skin patch that does not improve with the treatment it was given.

Does a Missed Diagnosis Always Mean Care Was Poor?

A missed diagnosis does not always mean that care fell below an appropriate standard. Some lesions are difficult to distinguish from harmless conditions, especially early in their development. Clinical judgement often depends on what can be seen at that point, the patient’s history and whether the lesion has shown concerning behaviour.

Good assessment involves more than a quick visual check. It includes listening to concerns, asking about changes, examining the relevant area and arranging dermoscopy, referral or biopsy when cancer cannot be excluded. If uncertainty remains, the plan should explain what symptoms or changes require the patient to seek further review.

What Should You Do If You Are Worried a Skin Cancer Has Been Missed?

Keep a simple record of when the lesion first appeared and how it has changed. Photographs taken in consistent lighting can help show growth, changes in colour or repeated crusting, although they do not replace a clinical examination. If you have been prescribed treatment for a skin condition and the area is not improving, ask for reassessment rather than continuing indefinitely.

It is reasonable to ask whether a dermatology opinion, dermoscopy or biopsy would help clarify the diagnosis. A specialist second opinion may be useful when a lesion remains unexplained, symptoms persist or the reassurance given does not match what is happening to the skin.

The important point is that ongoing change should lead to a fresh clinical decision, not simply another period of watchful waiting.

How Skin Cancer Is Confirmed

Clinical Examination

The first step is to examine the lesion and ask when it appeared, whether it has changed in size, shape, or colour, and whether it has bled, crusted, itched, or failed to heal. The clinician may also examine other areas of the skin and nearby lymph nodes.

A lesion that has remained unchanged for years may be assessed differently from one that has recently grown or started bleeding. This helps determine whether it needs monitoring, further testing or removal.

Dermoscopy

Dermoscopy uses a handheld device with magnification and lighting to reveal patterns and structures beneath the skin’s surface that are not visible to the naked eye. It is commonly used to assess suspicious moles, pigmented marks and other potentially cancerous lesions. While it can improve diagnostic accuracy and help determine whether a lesion needs removal or specialist review, a biopsy may still be needed if the appearance remains concerning.

Biopsy

A biopsy involves removing all or part of a suspicious lesion so a histopathologist can examine the tissue under a microscope. It is the most reliable way to confirm many types of skin cancer and identify the specific type involved.

The result helps determine whether further surgery, additional testing or other treatment is needed. If a lesion continues to change after an earlier reassuring result, it should be assessed again.

Why Delays Can Affect Treatment Decisions

When a clinician suspects skin cancer, prompt referral helps establish whether cancer is present and what treatment may be required. The NHS Faster Diagnosis Standard aims for patients referred urgently for suspected cancer to receive a diagnosis or have cancer ruled out within 28 days. Individual timing can still vary because some cases require biopsy, imaging or specialist multidisciplinary review.

Speed is important, but accuracy matters as well. The aim is not to rush people through a process without answers, but to avoid unnecessary delay when a suspicious lesion needs investigation. A clear pathway gives patients a practical route from concern to diagnosis and, where needed, treatment planning.

An oncology specialist can be particularly valuable when a skin cancer diagnosis is confirmed, uncertain or more complex than expected. Dr James Wilson can review the pathology, stage of disease and available treatment options, including private treatment, while helping patients understand what each decision means in practical terms. This is especially important for melanoma, squamous cell carcinoma, or cases where there is concern about spread, recurrence, or the need for treatment beyond surgery.

The Point Is Persistence, Not Panic

Most skin marks, moles and rashes are not cancer. However, a lesion that changes, bleeds, repeatedly crusts or fails to heal should not be ignored, especially if it does not fit the explanation originally given. There may not be one meaningful figure for skin cancer misdiagnosis, but there is a clear principle: persistent or changing skin lesions need reassessment.

If you remain concerned after an initial review, seeking a second opinion is sensible and appropriate. An earlier assessment can clarify whether a lesion is harmless, requires monitoring, or needs treatment. That is the practical value of acting on change before more time passes.

About Dr James Wilson

Dr James Wilson is a consultant clinical oncologist working in private practice in London, with expertise in skin cancer, its treatment and systemic care. His consultations include careful review of medical records, scans, diagnosis, and treatment options, with a written report provided after the appointment. He helps patients understand the options available and make more informed decisions regarding treatment of their condition.